Article Search

Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH

February 1, 2025

The addition of danicopan (factor D inhibitor) reduced extravascular hemolysis, so reduced anemia on those patients compared to ravulizumab or eculizumab.

Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism

October 1, 2022

A benign hematology article, not a large study but an eye opener.

Article Search
Article Search Form
Cancer Types
Filter by Cancer Types
Month Contributed
Show FCS Articles Only
Sort Order
Sort Order Field
Number of Posts

Article Archive (2021)

About This Site

FCS Hematology Oncology Review creates a platform for our physician network to observe the most recent articles and studies available in the oncology and hematology world. By sharing these articles we are building our wealth of knowledge of new observations and treatments as they come available.

Article Search

Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH

Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism

Keyword Search

Article Search

Cancer Types

Month Contributed

Show FCS Articles Only

Sort Order

Number of Posts

Menu

About This Site